Would you ever defer radiation in patients with primary brain tumors or would you manage these patients similarly to non-MS patients? How do you counsel MS patients regarding their risks?
At least one small series of 15 consecutive patients from Mayo suggested an increase in severe toxicity with older, large-field radiation (Miller, Robert C., et al. "Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience." International Journal of Radiation Oncology• Biology• Physics 66.4 (2006): 1178-1186.
I agree with @Tony J. Wang; in spite of the small ...